The Digestive Health Physicians Association (DHPA) and a broad coalition of 29 physician groups voiced strong opposition to H.R. 2143, legislation that would eliminate the in-office ancillary services exception (IOASE) and make it harder for physicians to coordinate care for their patients.
Protecting Patient Access to Integrated GI Care in the Independent Setting
In an age when quality of care, cost-effectiveness and transparency are more important than ever, data demonstrates that high-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting.
DHPA and 26 additional physician groups voiced strong support for S.966, the Medicare Care Coordination Improvement Act of 2019, bipartisan legislation that would substantially improve care coordination for patients, improve health outcomes and restrain costs by allowing physicians to participate and succeed in alternative payment models.
DHPA submitted comments in response to a Request for Information (RFI) from the Office of Inspector General (OIG) in the U.S. Department of Health and Human Services regarding the need to modernize the Anti-Kickback Statute. DHPA’s comment letter complements another set of comments submitted to CMS which focused on modernizing the Stark law to remove […]
DHPA President Dr. Michael Weinstein testified before the U.S. House Energy & Commerce Health Subcommittee during a hearing entitled “Examining Barriers to Expanding Innovative Value-Based Care in Medicare.” Dr. Weinstein testified that expanding Alternative Payment Models (APMs) to independent practices will enable health care to move to a more cost-efficient setting. Dr. Weinstein urged Congress […]
DHPA joined a coalition of 240 patient and provider groups signing onto a letter to U.S. Senate and U.S. House leaders asking them to urge the Centers for Medicare & Medicaid Services (CMS) to reconsider a proposal to allow Medicare Advantage plans to implement step therapy to manage Part B drugs. CMS originally announced the […]